Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-27

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for oxybutynin chloride from Advagen Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)